The company said it will use Veritas’ cannabis strain lead selection to assist its application to the Home Office Drugs Licensing and Compliance Unit for a medicinal cannabis growing licence.
READ: Sativa Investments refines Orderly Market Agreements to improve liquidity for NEX traded shares
In May, Sativa invested C$200,000 in Veritas.
Chief executive, Geremy Thomas, said: "A key part of Sativa's strategy is to target overseas investments that can be leveraged to assist the company commercially as it participates in the industry in the UK and wider Europe.
“In this case, Veritas' scientific knowledge of seed selection will expedite a potential UK licence application to enable Sativa to grow cannabis strains for its own research and development purposes including use by recipients of grants awarded by the Sativa Foundation."